Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson's Disease

Dopamine replacement therapy is useful for treating motor symptoms in the early phase of Parkinson's disease, but it is less effective in the long term. Electrical deep-brain stimulation is a valuable complement to pharmacological treatment but involves a highly invasive surgical procedure. We found that epidural electrical stimulation of the dorsal columns in the spinal cord restores locomotion in both acute pharmacologically induced dopamine-depleted mice and in chronic 6-hydroxydopamine–lesioned rats. The functional recovery was paralleled by a disruption of aberrant low-frequency synchronous corticostriatal oscillations, leading to the emergence of neuronal activity patterns that resemble the state normally preceding spontaneous initiation of locomotion. We propose that dorsal column stimulation might become an efficient and less invasive alternative for treatment of Parkinson's disease in the future.

[1]  P. J. Crockett,et al.  Alfvén Waves in the Lower Solar Atmosphere , 2009, Science.

[2]  S. Grillner,et al.  Neural bases of goal-directed locomotion in vertebrates—An overview , 2008, Brain Research Reviews.

[3]  Ilana Schlesinger,et al.  Paradoxical kinesia at war , 2007, Movement disorders : official journal of the Movement Disorder Society.

[4]  H. Bergman,et al.  Pathological synchronization in Parkinson's disease: networks, models and treatments , 2007, Trends in Neurosciences.

[5]  Rui M. Costa,et al.  Rapid Alterations in Corticostriatal Ensemble Coordination during Acute Dopamine-Dependent Motor Dysfunction , 2006, Neuron.

[6]  Y. Ben-Shlomo,et al.  Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. , 2006, Brain : a journal of neurology.

[7]  C. DeGiorgio,et al.  Pilot Study of Trigeminal Nerve Stimulation (TNS) for Epilepsy: A Proof‐of‐Concept Trial , 2006, Epilepsia.

[8]  J. Mink,et al.  Deep brain stimulation. , 2006, Annual review of neuroscience.

[9]  David J. Brooks,et al.  Imaging in Parkinson’s Disease: The Role of Monoamines in Behavior , 2006, Biological Psychiatry.

[10]  W. Wetsel,et al.  Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease , 2005, PLoS biology.

[11]  Charles J. Wilson,et al.  The Mechanism of Intrinsic Amplification of Hyperpolarizations and Spontaneous Bursting in Striatal Cholinergic Interneurons , 2005, Neuron.

[12]  Haruhiko Kishima,et al.  Functional Recovery in a Primate Model of Parkinson's Disease following Motor Cortex Stimulation , 2004, Neuron.

[13]  H. Eichenbaum,et al.  Oscillatory Entrainment of Striatal Neurons in Freely Moving Rats , 2004, Neuron.

[14]  Y. Smith,et al.  The thalamostriatal system: a highly specific network of the basal ganglia circuitry , 2004, Trends in Neurosciences.

[15]  P. Brown,et al.  Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. , 2004, Brain : a journal of neurology.

[16]  A. Benabid Deep brain stimulation for Parkinson’s disease , 2003, Current Opinion in Neurobiology.

[17]  S. Fahn Description of Parkinson's Disease as a Clinical Syndrome , 2003, Annals of the New York Academy of Sciences.

[18]  A. Björklund,et al.  l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function , 2002, Neurobiology of Disease.

[19]  Ian Q. Whishaw,et al.  Animal models of neurological deficits: how relevant is the rat? , 2002, Nature Reviews Neuroscience.

[20]  A. Oliviero,et al.  Dopamine Dependency of Oscillations between Subthalamic Nucleus and Pallidum in Parkinson's Disease , 2001, The Journal of Neuroscience.

[21]  Erika E. Fanselow,et al.  Reduction of Pentylenetetrazole-Induced Seizure Activity in Awake Rats by Seizure-Triggered Trigeminal Nerve Stimulation , 2000, The Journal of Neuroscience.

[22]  Mustafa M. Husain,et al.  Vagus nerve stimulation: a new tool for brain research and therapy∗ , 2000, Biological Psychiatry.

[23]  D. Gash,et al.  Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat , 1994, Brain Research.

[24]  G. Mogenson,et al.  Decreases in rat locomotor activity as a result of changes in synaptic transmission to neurons within the mesencephalic locomotor region. , 1993, Canadian journal of physiology and pharmacology.

[25]  M. Glickstein,et al.  Paradoxical movement in Parkinson's disease , 1991, Trends in Neurosciences.

[26]  M. Delong,et al.  Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.

[27]  A. Lees,et al.  The impact of treatment with levodopa on Parkinson's disease. , 1980, The Quarterly journal of medicine.

[28]  O. Hornykiewicz,et al.  The neurochemistry of Parkinson's disease: effect of L-dopa therapy. , 1975, The Journal of pharmacology and experimental therapeutics.

[29]  O. Hornykiewicz L-DOPA: From a biologically inactive amino acid to a successful therapeutic agent , 2002, Amino Acids.

[30]  A. Carlsson Biochemical and pharmacological aspects of Parkinsonism. , 1972, Acta neurologica Scandinavica. Supplementum.

[31]  P. Wall The sensory and motor role of impulses travelling in the dorsal columns towards cerebral cortex. , 1970, Brain : a journal of neurology.